The proximal origin of SARS-CoV-2
- PMID: 32284615
- PMCID: PMC7095063
- DOI: 10.1038/s41591-020-0820-9
The proximal origin of SARS-CoV-2
Conflict of interest statement
R.F.G. is co-founder of Zalgen Labs, a biotechnology company that develops countermeasures to emerging viruses.
Figures

Comment in
-
SARS-CoV-2: Combating Coronavirus Emergence.Immunity. 2020 May 19;52(5):734-736. doi: 10.1016/j.immuni.2020.04.016. Epub 2020 May 8. Immunity. 2020. PMID: 32392464 Free PMC article.
-
SARS-CoV-2 pandemic in the western world: the lessons learned.J R Coll Physicians Edinb. 2020 Jun;50(2):110-111. doi: 10.4997/JRCPE.2020.205. J R Coll Physicians Edinb. 2020. PMID: 32568277 No abstract available.
-
On the origins of SARS-CoV-2.Nat Med. 2021 Jan;27(1):9. doi: 10.1038/s41591-020-01205-5. Nat Med. 2021. PMID: 33442004 No abstract available.
-
SARS-CoV-2 not made in a laboratory.J Paediatr Child Health. 2021 Jan;57(1):168. doi: 10.1111/jpc.15203. J Paediatr Child Health. 2021. PMID: 33493372 Free PMC article. No abstract available.
-
US COVID-origins hearing renews debate over lab-leak hypothesis.Nature. 2023 Mar;615(7952):380-381. doi: 10.1038/d41586-023-00701-1. Nature. 2023. PMID: 36890328 No abstract available.
References
-
- Gorbalenya AE, et al. bioRxiv. 2020 doi: 10.1101/2020.02.07.937862. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous